Amneal Pharmaceuticals Inc (AMRX)
6.00
+0.06
(+1.01%)
USD |
NASDAQ |
Apr 30, 12:57
Amneal Pharmaceuticals Price to Book Value: 93.12 for April 30, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 29, 2024 | 92.19 |
April 26, 2024 | 91.10 |
April 25, 2024 | 91.57 |
April 24, 2024 | 93.90 |
April 23, 2024 | 83.81 |
April 22, 2024 | 83.34 |
April 19, 2024 | 84.12 |
April 18, 2024 | 83.19 |
April 17, 2024 | 84.74 |
April 16, 2024 | 84.59 |
April 15, 2024 | 85.98 |
April 12, 2024 | 85.67 |
April 11, 2024 | 88.31 |
April 10, 2024 | 88.47 |
April 09, 2024 | 88.93 |
April 08, 2024 | 93.12 |
April 05, 2024 | 94.98 |
April 04, 2024 | 92.50 |
April 03, 2024 | 93.43 |
April 02, 2024 | 90.17 |
April 01, 2024 | 93.90 |
March 28, 2024 | 94.05 |
March 27, 2024 | 94.98 |
March 26, 2024 | 90.79 |
March 25, 2024 | 91.72 |
Date | Value |
---|---|
March 22, 2024 | 94.21 |
March 21, 2024 | 97.62 |
March 20, 2024 | 94.36 |
March 19, 2024 | 98.40 |
March 18, 2024 | 91.72 |
March 15, 2024 | 85.36 |
March 14, 2024 | 83.65 |
March 13, 2024 | 83.81 |
March 12, 2024 | 82.41 |
March 11, 2024 | 83.50 |
March 08, 2024 | 83.65 |
March 07, 2024 | 82.41 |
March 06, 2024 | 82.41 |
March 05, 2024 | 82.88 |
March 04, 2024 | 83.81 |
March 01, 2024 | 84.90 |
February 29, 2024 | 85.67 |
February 28, 2024 | 85.55 |
February 27, 2024 | 88.49 |
February 26, 2024 | 90.20 |
February 23, 2024 | 89.89 |
February 22, 2024 | 88.18 |
February 21, 2024 | 88.80 |
February 20, 2024 | 89.58 |
February 16, 2024 | 91.44 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6384
Minimum
Aug 27 2019
98.40
Maximum
Mar 19 2024
7.608
Average
1.980
Median
Price to Book Value Benchmarks
Fate Therapeutics Inc | 1.076 |
Ocular Therapeutix Inc | 7.983 |
Editas Medicine Inc | 1.234 |
AnaptysBio Inc | 7.081 |
Stoke Therapeutics Inc | 3.238 |
Price to Book Value Related Metrics
PS Ratio | 0.4457 |
Price to Free Cash Flow | 3.859 |
Price | 6.00 |
Earnings Yield | -8.17% |
Market Cap | 1.842B |
Operating PE Ratio | 4.757 |